Clinical Trials Browser

Phase 2 × Withdrawn × Sodium Chloride × Clear all

NCT02682485 2023-04-26

SES-DTA

Phase 2 Withdrawn

Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

NCT00967512 2014-09-18

Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course

Phase 2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00681148 2013-11-21

Botulinum Toxin Injection With Prostate Brachytherapy

Phase 2 Withdrawn

Prostatic Neoplasms, Lower Urinary Tract Symptoms